Published in Regen Med on February 16, 2017
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03
Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol (2005) 5.20
Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol (2010) 3.44
Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A (2008) 3.09
Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol (2009) 3.07
Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2011) 3.06
CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem (2009) 2.81
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2008) 2.27
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2007) 1.92
Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc (1995) 1.88
Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater (2011) 1.81
IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol (2012) 1.81
Arginase modulates nitric oxide production in activated macrophages. Am J Physiol (1998) 1.63
The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med (1997) 1.59
Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J (2010) 1.44
Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J (2002) 1.42
Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J (2011) 1.40
Macrophage invasion does not contribute to muscle membrane injury during inflammation. J Leukoc Biol (1999) 1.38
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis (2013) 1.32
Epidemiology of peripheral artery disease. Circ Res (2015) 1.30
Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc Sport Sci Rev (2009) 1.27
Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J (2013) 1.22
Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells (2013) 1.22
Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med (1999) 1.21
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J Immunol (2000) 1.21
Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding. Tissue Eng Part A (2010) 1.20
Macrophages: supportive cells for tissue repair and regeneration. Immunobiology (2013) 1.10
Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation. Stem Cells (2013) 1.05
Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs (2009) 1.04
Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther (2012) 1.01
Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J Immunol (2013) 1.01
Adipose-derived stem cells promote angiogenesis and tissue formation for in vivo tissue engineering. Tissue Eng Part A (2013) 1.01
Mesenchymal stem cell-educated macrophages. Transplant Res (2012) 1.00
Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. J Cardiovasc Pharmacol Ther (2012) 1.00
Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur J Vasc Endovasc Surg (2004) 1.00
Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.99
Therapeutic angiogenesis by autologous adipose-derived regenerative cells: comparison with bone marrow mononuclear cells. Am J Physiol Heart Circ Physiol (2014) 0.95
Comparative characterization of mesenchymal stem cells from eGFP transgenic and non-transgenic mice. BMC Cell Biol (2009) 0.95
Shared signaling systems in myeloid cell-mediated muscle regeneration. Development (2014) 0.95
Macrophage activation and skeletal muscle healing following traumatic injury. J Pathol (2014) 0.91
Interleukin 6 mediates the therapeutic effects of adipose-derived stromal/stem cells in lipopolysaccharide-induced acute lung injury. Stem Cells (2014) 0.90
Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One (2012) 0.89
Angiogenesis: the role of PDGF-BB on adipose-tissue derived stem cells (ASCs). Clin Hemorheol Microcirc (2011) 0.89
Local delivery of polarized macrophages improves reperfusion recovery in a mouse hind limb ischemia model. PLoS One (2013) 0.87
Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res (2015) 0.87
Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis. Mol Ther (2013) 0.86
Unsorted human adipose tissue-derived stem cells promote angiogenesis and myogenesis in murine ischemic hindlimb model. Microvasc Res (2010) 0.85
Therapeutic angiogenesis of three-dimensionally cultured adipose-derived stem cells in rat infarcted hearts. Cytotherapy (2013) 0.82
[Peripheral artery disease: pathophysiology, diagnosis and treatment]. Rev Esp Cardiol (2007) 0.82
Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling. Integr Biol (Camb) (2016) 0.82
GDNF secreted from adipose-derived stem cells stimulates VEGF-independent angiogenesis. Oncotarget (2016) 0.80
Role of adipose-derived stem cells in enhancing angiogenesis early after aspirated fat transplantation: induction or differentiation? Cell Biol Int (2013) 0.80
The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury. PLoS One (2015) 0.78
Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31. Stem Cells Transl Med (2016) 0.76